Showing results (11-20 of 248) with videos related to
Sort By:
Pageof 25
Nature Reviews. Drug Discovery|August 19, 2014
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersKatrina J Falkenberg, Ricky W JohnstoneEpigenomics|December 1, 2011
Promises and challenges of anticancer drugs that target the epigenomeInge Verbrugge, Ricky W Johnstone, Michael BotsInvestigational New Drugs|December 17, 2010
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effectMichael Dickinson, Ricky W Johnstone, H Miles PrinceCell Cycle (Georgetown, Tex.)|May 22, 2004
Histone-deacetylase inhibitors for the treatment of cancerRalph K Lindemann, Brian Gabrielli, Ricky W JohnstoneImmunological Reviews|November 6, 2007
From cancer immunosurveillance to cancer immunotherapyJohn Stagg, Ricky W Johnstone, Mark J SmythAdvances in Cancer Research|October 24, 2012
Intrinsic and extrinsic apoptotic pathway signaling as determinants of histone deacetylase inhibitor antitumor activityGeoffrey M Matthews, Andrea Newbold, Ricky W JohnstoneNature Reviews. Drug Discovery|September 7, 2006
Anticancer activities of histone deacetylase inhibitorsJessica E Bolden, Melissa J Peart, Ricky W JohnstoneNature Reviews. Cancer|September 25, 2008
The TRAIL apoptotic pathway in cancer onset, progression and therapyRicky W Johnstone, Ailsa J Frew, Mark J SmythCancer Letters|April 11, 2009
Enhancing the apoptotic and therapeutic effects of HDAC inhibitorsAilsa J Frew, Ricky W Johnstone, Jessica E BoldenFuture Oncology (London, England)|June 13, 2009
Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumorsH Miles Prince, Mark J Bishton, Ricky W JohnstonePageof 25